Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
/Free Sign Up
 Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Axsome Therapeutics Inc (AXSM)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Axsome Therapeutics Inc's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
33.35 +0.19    +0.57%
02/12 - Closed. Currency in USD ( Disclaimer )
After Hours
32.40
-0.95
-2.85%
18:53:03 - Real-time Data
Type:  Equity
Market:  United States
ISIN:  US05464T1043 
CUSIP:  05464T104
  • Volume: 463,445
  • Bid/Ask: 32.39 / 33.98
  • Day's Range: 32.08 - 33.63
Axsome Therapeutics Inc 33.35 +0.19 +0.57%

AXSM Earnings

 
The latest earnings per stock, revenues and financial reports for Axsome Therapeutics Inc (AXSM).
Latest Release

Nov 08, 2021

EPS / Forecast

-0.93 / -0.9538

Revenue / Forecast

0.00 / 0.00

Revenue
EPS
 Forecast
 
Release Date Period End EPS /  Forecast Revenue /  Forecast
Mar 17, 2022 12/2021 -- /  -1.08 -- /  63.4K
Nov 08, 2021 09/2021 -0.93 /  -0.9538 0.00 /  0.00
Aug 09, 2021 06/2021 -0.86 /  -0.9191 0.00 /  0.00
May 10, 2021 03/2021 -0.78 /  -0.8189 0.00 /  0.00
Mar 01, 2021 12/2020 -0.78 /  -0.7521 0.00 /  0.00
Nov 05, 2020 09/2020 -0.61 /  -0.5718 0.00 /  0.00
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

AXSM Comments

Write your thoughts about Axsome Therapeutics Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Meka Raju
Meka Raju Aug 23, 2021 6:48AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
FDA positive news?
Reply
1 0
Report
Meka Raju
Meka Raju Aug 23, 2021 6:32AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
What
Reply
0 0
Report
Meka Raju
Meka Raju Aug 20, 2021 7:37PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Slowly
Reply
0 0
Report
Talala Rus
Talala Rus Aug 10, 2021 7:40AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Time to buy today
Reply
4 1
Report
rashed marak
rashed marak Aug 09, 2021 4:45PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Will bounce 20% tomorrow
Reply
2 3
Report
Ab High
Ab High Aug 09, 2021 3:06PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
27.9 9/aug
Reply
1 0
Report
Rony Derra
Rony Derra Jan 11, 2021 11:39AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
any comments for 2021?
Reply
1 7
Report
Алексей Корнев
Алексей Корнев Jun 29, 2020 9:44AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Holy cow! It was a rehearsal? Just smile and wait guys.
Reply
4 0
Report
jonathan ehlebracht
jonathan ehlebracht Apr 16, 2020 12:46PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Defintely time to buy not sell. Company is wxecpted to start brining in revenue this year so stock price will began to grow rapidly. Selling now is a BIG mistake
Reply
14 2
Report
Rustam Garaev
235666 Jan 09, 2020 11:33PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Buy this even at 90$ A huge massive winner for 2020
Reply
7 2
Report
Krunoslav Zovko
Krunoslav Zovko Jan 09, 2020 11:33PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
whay is massive winner?*
Reply
0 1
Report
shay levi
shay levi Dec 19, 2019 10:36AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I don't understand why to buy it on 100 when the company offers on 87
Reply
2 0
Report
Show previous replies (1)
Lex Talionis
Lex Talionis Dec 19, 2019 10:36AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Only 2 million shares offered, not enough for demand... especially when short sellers hold at least 6 million shares. Price target was just raised to 170 by analyst, and that's without considering upcoming results of migraine trial which could raise it much higher.
Reply
1 0
Report
Dustin Whitsett
Goin_Broke Dec 19, 2019 10:36AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Lex Talionis  After watching and trading AMRN for over a year its crazy to watch a bio explode
Reply
0 0
Report
shay levi
shay levi Dec 19, 2019 10:36AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
So what are you saying Goin? It's just a bubble?
Reply
0 0
Report
Lex Talionis
Lex Talionis Dec 19, 2019 10:36AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Market cap is still less than half that of say AMRN and SAGE; and AXSM has equal or broader pipeline. I don't see this collapsing any time soon, even if migraine trial disappoints (depression drug combo alone could carry this valuation).
Reply
1 0
Report
Dustin Whitsett
Goin_Broke Dec 19, 2019 10:36AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
shay levi  . No just fun to watch. I'm not a bull or bear.
Reply
0 0
Report
Lex Talionis
Lex Talionis Dec 18, 2019 6:37PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Announces public offering after close; goes UP 5% in AH trade. o_O Looks like $100 will come before the migraine trial results
Reply
0 0
Report
The Lost
The Lost Dec 16, 2019 9:49AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Now I sell the falling knife
Reply
0 0
Report
Lex Talionis
Lex Talionis Dec 16, 2019 9:49AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Might regret it, results for the migraine trial coming soon. Nothing wrong with securing profit though!
Reply
0 0
Report
The Lost
The Lost Dec 16, 2019 9:49AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I got in at 14, no regrets. Probably will keep a 3rd
Reply
1 0
Report
The Lost
The Lost Dec 16, 2019 9:49AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Check out Wavelife sciences, it just dropped today, but I've sold and resold it 3 times now on each drop with 30 to 50 percent gains
Reply
1 0
Report
Lex Talionis
Lex Talionis Dec 16, 2019 7:45AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Whoooooa, up 66% premarket! 100$ looking possible before EOY
Reply
1 0
Report
Lex Talionis
Lex Talionis Dec 16, 2019 7:45AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Up to 83% now... what a juggernaut. Crazy to think it was a 2 dollar stock less than a year ago.
Reply
1 0
Report
Michelle Saint
Michelle Saint Dec 06, 2019 11:50AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Great time to buy
Reply
2 0
Report
nima barzegarii
nima barzegarii Nov 10, 2019 12:53PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
falling knife, selling shares to survive? any real investor knows any investment in pharmaceuticals would base on its pipeline, go educate yourself before you give your 2 cents which ain't worth a pack of chicklets from the homeless kid, who shares the same inversion narrative you baby investors. Good luck with that made up philosophy. While you're at it, riddle me this. Can you shoot me any other stock that went from a penny stock to a high of 30, with the lowest being in the high 18's at the lowest foundation support, which got back all its loss before the 2nd week? This stock will be worth triple digits by the end of 2020, thats with just one positive readout.
Reply
1 0
Report
The Lost
The Lost Sep 11, 2019 1:59AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
If you haven't already bought it. Buy now even at 24. Strong pipeline for end of year. Plus all the insider buys and institutions should tell you something. I will sell at 36 having had bought at 12.31
Reply
5 3
Report
Darrius Starks
Darrius Starks Sep 11, 2019 1:59AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Buy a falling knife? Ok
Reply
2 1
Report
aminur rab
aminur rab Sep 11, 2019 1:59AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
no revenue no fda and selling shares to survive... jumped from 3 to 30 in 6 months .... will see 7-8$ within next 30 days or so
Reply
0 1
Report
alessio di leonardo
alessio di leonardo Sep 11, 2019 1:59AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
aminur rab  sure
Reply
1 0
Report
The Lost
The Lost Sep 11, 2019 1:59AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
What did you say?
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email